David Akhavan

3.1k citations

19 papers · 1.1k indexed · h-index 11

Impact in

Genetics top 5%
- Glioma Diagnosis and Treatment
Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Oncology 8
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 3
Molecular Biology 6
- Ion channel regulation and function 2

Co-authors: Paul S. Mischel (4 shared papers)Timothy F. Cloughesy (2 shared papers)Larry J. W. Miercke (3 shared papers)Robert M. Stroud (2 shared papers)William Harries (2 shared papers)Shahram Khademi (2 shared papers)Christine E. Brown (2 shared papers)Darya Alizadeh (2 shared papers)
Journals: Proceedings of the National Academy of Sciences (2 papers)Cell Metabolism (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Cancer Microenvironment (1 paper)Journal of Visualized Experiments (1 paper)
Partner nations: United States Australia United Kingdom

In The Last Decade

David Akhavan

17 papers receiving 1.1k citations

Peers

Countries citing papers authored by David Akhavan

Since Specialization

Citations

This map shows the geographic impact of David Akhavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Akhavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Akhavan more than expected).

Fields of papers citing papers by David Akhavan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Akhavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Akhavan. The network helps show where David Akhavan may publish in the future.

Co-authors

The 25 scholars most cited alongside David Akhavan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Akhavan Line = papers co-authored together David Akhavan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc Cell Metabolism ·Kenta Masui, Kazuhiro Tanaka, David Akhavan, Ivan Babić, Beatrice Gini, Tomoo Matsutani, Akio Iwanami, Feng Liu, Genaro R. Villa, Yuchao Gu, Carl Campos, Shaojun Zhu, Huijun Yang, William H. Yong, Timothy F. Cloughesy, Ingo K. Mellinghoff, Webster K. Cavenee, Reuben J. Shaw, Paul S. Mischel	2013	341
2	The channel architecture of aquaporin 0 at a 2.2-Å resolution Proceedings of the National Academy of Sciences ·William Harries, David Akhavan, Larry J. W. Miercke, Shahram Khademi, Robert M. Stroud	2004	220
3	CAR T cells for brain tumors: Lessons learned and road ahead Immunological Reviews ·David Akhavan, Darya Alizadeh, Dongrui Wang, Michael R. Weist, Jennifer Kelly Shepphird, Christine E. Brown	2019	164
4	mTOR signaling in glioblastoma: lessons learned from bench to bedside Neuro-Oncology ·David Akhavan, Timothy F. Cloughesy, Paul S. Mischel	2010	146
5	Glycerol facilitator GlpF and the associated aquaporin family of channels Current Opinion in Structural Biology ·Robert M. Stroud, Larry J. W. Miercke, Joseph D. O’Connell, Shahram Khademi, John K. Lee, Jonathan Remis, William Harries, Yaneth Robles, David Akhavan	2003	65
6	Pilot Study on “Pericytic Mimicry” and Potential Embryonic/Stem Cell Properties of Angiotropic Melanoma Cells Interacting with the Abluminal Vascular Surface Cancer Microenvironment ·Claire Lugassy, Madhuri Wadehra, Xinmin Li, Mirko Corselli, David Akhavan, Scott W. Binder, Bruno Péault, Alistair J. Cochran, Paul S. Mischel, Hynda K. Kleinman, Raymond L. Barnhill	2012	45
7	Activation of Src induces mitochondrial localisation of de2-7EGFR (EGFRvIII) in glioma cells: implications for glucose metabolism Journal of Cell Science ·Anna N. Cvrljevic, David Akhavan, Min Wu, Paul Martinello, Frank B. Furnari, Amelia J. Johnston, Deliang Guo, Lisa Pike, Webster K. Cavenee, Andrew M. Scott, Paul S. Mischel, Nick Hoogenraad, Terrance G. Johns	2011	36
8	The Effects of Time to Treatment Initiation for Patients With Non–small-cell Lung Cancer in the United States Clinical Lung Cancer ·Taylor R. Cushman, Bernard L. Jones, David Akhavan, Chad G. Rusthoven, Vivek Verma, Ravi Salgia, Mina S. Sedrak, Erminia Massarelli, James W. Welsh, Arya Amini	2020	24
9	De novodesign of an IL-4 antagonist and its structure at 1.9 Å Proceedings of the National Academy of Sciences ·Sherry L. LaPorte, C.M. Forsyth, Brian C. Cunningham, Larry J. W. Miercke, David Akhavan, R. M. Stroud	2005	22
10	Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies Cancer Biotherapy and Radiopharmaceuticals ·David Akhavan, Paul J. Yazaki, Dave Yamauchi, Jennifer Simpson, Paul Frankel, James R. Bading, David Colcher, Kofi Poku, Yi‐Jen Chen, Dean Lim, Mihaela Cristea, Anna M. Wu, John E. Shively, Jeffrey Y.C. Wong	2020	19
11	EGFR as a potent CAR T target in triple negative breast cancer brain metastases Breast Cancer Research and Treatment ·Siddharth Subham, John D. Jeppson, Colette R. Worcester, Bryan Schatmeyer, Jie Zhao, Rashna Madan, Nelli S. Lakis, Bruce F. Kimler, Joseph P. McGuirk, Ronald C. Chen, Shane R. Stecklein, David Akhavan	2022	15
12	Advances in computational and translational approaches for malignant glioma Frontiers in Physiology ·Adip G. Bhargav, Joseph S. Domino, Anthony M. Alvarado, Chad A. Tuchek, David Akhavan, Paul J. Camarata	2023	5
13	Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review EP Europace ·Amulya Gupta, Zeeshan Sattar, Nourhan Chaaban, Sagar Ranka, Cameron Carlson, Farhad Sami, Clifford G. Robinson, Phillip S. Cuculich, Seth H. Sheldon, Madhu Reddy, David Akhavan, Amit Noheria	2024	5
14	Disparities Predict for Higher Rates of Cut-through Hysterectomies in Locally Advanced Cervical Cancer American Journal of Clinical Oncology ·Arya Amini, Tyler P. Robin, Chad G. Rusthoven, Tracey E. Schefter, David Akhavan, Yi‐Jen Chen, Scott Glaser, Bradley R. Corr, Kimlin Ashing, Christine M. Fisher	2018	4
15	Evaluation of the Immunomodulatory Effects of Radiation for Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme Cells ·David Akhavan, Siddharth Subham, John D. Jeppson, Brenda Aguilar, Robyn A. Wong, Jonathan Hibbard, Susanta Hui, Jeffrey Y.C. Wong, Stephen J. Forman, Darya Alizadeh, Christine E. Brown	2024	3
16	Factors Predicting for Early Mortality in Non-Small Cell Lung Cancer International Journal of Radiation OncologyBiologyPhysics ·Arya Amini, Scott Glaser, David Akhavan, R. Li, Rebecca A. Nelson, William A. Stokes, Marianna Koczywas, Karen L. Reckamp, Ravi Salgia, Laurie E. Gaspar, Brian D. Kavanagh, Chad G. Rusthoven, A.K. Liu	2018	1
17	Abstract 3170: Targeting tumor-associated astrocyte dependence in glioblastoma treatment Cancer Research ·Joseph S. Domino, Anthony M. Alvarado, Levi Arnold, Sumedha Gunewardena, David Akhavan, Sufi M. Thomas	2021	1
18	Rapid <em>In Vitro</em> Cytotoxicity Evaluation of Jurkat Expressing Chimeric Antigen Receptor using Fluorescent Imaging Journal of Visualized Experiments ·Siddharth Subham, John D. Jeppson, Benjamin K. Gibbs, Jacqueline Babai, Riza Alker, Andrew K. Godwin, David Akhavan	2023	0
19	Cardiac stereotactic radiotherapy for refractory ventricular tachycardia in a patient with wireless left ventricular endocardial stimulation system HeartRhythm Case Reports ·Sania Jiwani, David Akhavan, Madhu Reddy, Amit Noheria	2023	0

About David Akhavan

David Akhavan is a scholar working on Oncology, Molecular Biology, Genetics, Pulmonary and Respiratory Medicine and Immunology, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers), Glioma Diagnosis and Treatment (3 papers), Cardiac Arrhythmias and Treatments (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Ion channel regulation and function (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (198 citations), Cancer Research (221 citations), Molecular Biology (725 citations), Oncology (263 citations) and Immunology (129 citations). David Akhavan has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Paul S. Mischel, Timothy F. Cloughesy, Larry J. W. Miercke, Robert M. Stroud, William Harries, Shahram Khademi, Christine E. Brown, Darya Alizadeh, Dongrui Wang and Jennifer Kelly Shepphird. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cell Metabolism, International Journal of Radiation Oncology*Biology*Physics, Cancer Microenvironment and Journal of Visualized Experiments.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact